Page 16 - Pharma Stocks
Stocks to Watch: TCS, Paytm, PTC, Lodha, Heritage Foods, Electronics Mart
Stocks to Watch: TCS and other IT stocks in focus, as the Tata Group IT major will be reporting its Q3 earnings on Monday.
 "Stocks to Watch: TCS, Paytm, PTC, Lodha, Heritage Foods, Electronics Mart")
Stocks to Watch: Elin Electronics, Cipla, Eicher Motors, RIL, Banks, Pharma
Stocks to Watch: Elin Electronics to debut today, the stock is likely to list on a quiet note.
Pharma stocks upbeat amid Covid-19 scare; Divi's, Lupin can gain up to 10%
Technically, the Nifty Pharma index needs to immediate hurdle at 13,500, for further upside to 14,250.
 "Pharma stocks upbeat amid Covid-19 scare; Divi's, Lupin can gain up to 10%")
Stock of this PSU pharma company has zoomed 61% in 3 days on heavy volumes
The stock was locked in the 20% upper circuit; around 1.4 million shares, representing 3.2 per cent of total equity of the pharmaceutical company, changed hands on bourses
 "Stock of this PSU pharma company has zoomed 61% in 3 days on heavy volumes")
Mehul Kothari recommends Biocon, Aurobindo Pharma for trading gains
According to the technical analyst from Anand Rathi, Aurobindo Pharma can rally to Rs 490; while Biocon can jump to Rs 295.
 "Mehul Kothari recommends Biocon, Aurobindo Pharma for trading gains")
Healthcare stocks rally up to 8% as Covid cases spurt in China, Japan
Reports suggest that Union Health Minister Mansukh Mandaviya will review the Covid-19 pandemic situation, in view of a spurt in COVID-19 cases in Japan, South Korea, Brazil, China and the US.
 "Healthcare stocks rally up to 8% as Covid cases spurt in China, Japan")
Sun Pharma slips nearly 4% as USFDA issues import alert on Halol facility
For the year ended March 31, 2022, supplies to the US market from the Halol facility accounted for approximately 3 per cent of the company's consolidated revenues.
 "Sun Pharma slips nearly 4% as USFDA issues import alert on Halol facility")
Laurus Labs hits 52-week low, tanks 7% on margin concerns
Laurus has witnessed severe pricing pressure and lower volumes in its ARV formulations portfolio for five quarters now, resulting in significant pressure on core margins, say analyst.
 "Laurus Labs hits 52-week low, tanks 7% on margin concerns")
Stocks to Watch: Hero MotoCorp, Castrol, Tata Consumer, HFCL, Bikaji Foods
Stocks to Watch Today: Bikaji Foods, Castrol, Hero MotoCorp, Godrej Properties, Tat Consumer, pharma and insurance related shares are likely to be in focus on Monday.
 "Stocks to Watch: Hero MotoCorp, Castrol, Tata Consumer, HFCL, Bikaji Foods")
Indoco Remedies hits 8-month high on hopes of margin boost; stock surges 7%
In the past one week, it rallied 17 per cent, as against 0.35 per cent rise in the S&P BSE Sensex
Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
According to reports, ED has arrested Sarath Reddy, director of Aurobindo Pharma, under the money laundering act in the now scrapped Delhi Excise policy case.
 "Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED")
HUL, GSK Asia to scrap distribution pact for OTC products by next year
In 2018, HUL had announced that GSK Consumer Healthcare will merge with HUL in an all-stock deal
 "HUL, GSK Asia to scrap distribution pact for OTC products by next year")
Brokerages downgrade Divi's Labs post Q2 letdown; stock falls 11% in 2 days
EBITDA margins declined 767 bps YoY to 33.5 per cent due to high energy and transport costs.
 "Brokerages downgrade Divi's Labs post Q2 letdown; stock falls 11% in 2 days")
Cipla Q2 PAT up 11% PAT to Rs 789 cr on strong Covid-adjusted growth rate
The company is de-risking key product Abraxane in case the Goa plant FDA issue is not cleared immediately
 "Cipla Q2 PAT up 11% PAT to Rs 789 cr on strong Covid-adjusted growth rate")
We thrive on products that have limited competition: Top Sun Pharma execs
In a Q&A, the firm's US business head and its group CFO talk about their plans to scale the specialty products business further, and dwell on the company's strategies post-pandemic
 "We thrive on products that have limited competition: Top Sun Pharma execs")
Max Healthcare rallies 5%; hits record high on healthy Q2 results
The growth in Q2FY23 revenue and operating EBITDA were driven by higher occupancies, improved payor mix, and increased ARR in OPD.
 "Max Healthcare rallies 5%; hits record high on healthy Q2 results")
Pharma shares may turnaound soon; Cipla, Sun Pharma, Granules can gain 20%
What do expect from pharma stocks over the next few weeks? Here's what technical charts suggest.
 "Pharma shares may turnaound soon; Cipla, Sun Pharma, Granules can gain 20%")
Sun Pharma gains 2%, conquers Rs 1,000-mark after gap of over 7 years
The stock traded higher for the third straight day and has gained nearly 4 per cent during the period. It quoted at its highest level since May 2015.
Gland Pharma plunges 13%, hits 52-week low on disappointing Q2 results
Earnings before interest, taxes, depreciation, and amortization (EBITDA) margin contracted 150 bps to 33 per cent from 38 per cent in a year ago quarter.
 "Gland Pharma plunges 13%, hits 52-week low on disappointing Q2 results")
Sensex snaps 7-day winning run, falls 288 pts; RIL slips 1.5%, Nestle 3%
CLOSING BELL: The top drags were Nestle, Bajaj Finserv, HUL, Kotak Bank, RIL, HDFC, Bajaj Finance, Asian Paints, and IndusInd Bank as they fell in the range of 1 per cent to 3 per cent
 "Sensex snaps 7-day winning run, falls 288 pts; RIL slips 1.5%, Nestle 3%")